HRT Financial’s Maxim Integrated Products MXIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-6,996
Closed -$620K – 3362
2020
Q4
$620K Buy
+6,996
New +$552K 0.01% 910
2020
Q3
– Sell
-4,884
Closed -$296K – 2540
2020
Q2
$296K Sell
4,884
-9,539
-66% -$531K 0.01% 994
2020
Q1
$701K Buy
+14,423
New +$827K 0.05% 322
2019
Q3
– Sell
-14,210
Closed -$850K – 1680
2019
Q2
$850K Buy
14,210
+6,495
+84% +$370K 0.05% 304
2019
Q1
$410K Buy
+7,715
New +$415K 0.06% 222
2018
Q4
– Sell
-5,463
Closed -$308K – 799
2018
Q3
$308K Sell
5,463
-6,979
-56% -$421K 0.05% 246
2018
Q2
$729K Buy
+12,442
New +$724K 0.27% 64

Other funds holding MXIM

HRT Financial's MXIM Position: Q1 2021 in Review

HRT Financial sold out of Maxim Integrated Products (MXIM) in Q1 2021, closing a stake of 6,996 shares — an estimated $620K sold.

HRT Financial first reported a position in MXIM in Q2 2018 and held it in 7 quarters. The position peaked at $850K in Q2 2019. 623 funds tracked by Wall St. Rank hold MXIM as of Q1 2021.

  • HRT Financial reported no remaining Maxim Integrated Products position as of Q1 2021 after selling out during the quarter.
  • HRT Financial sold 6,996 Maxim Integrated Products shares in Q1 2021, an estimated $620K.
  • HRT Financial first reported a position in Maxim Integrated Products in Q2 2018 and held it in 7 quarters.
  • HRT Financial's Maxim Integrated Products position peaked at $850K in Q2 2019.
  • 623 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q1 2021.

Based on HRT Financial's 13F filing for Q1 2021, filed 17 May 2021.